Boye ME, Houghton K, Stull DE, Ainsworth C, Price GL. Estimating the effects of patient-reported outcome (PRO) diarrhea and pain measures on PRO fatigue: data analysis from a phase 2 study of abemaciclib monotherapy, a CDK4 and CDK6 inhibitor, in patients with HR+/HER2- breast cancer, after chemotherapy for metastatic disease: MONARCH 1. Poster presented at the 2017 ASCO Annual Meeting; June 4, 2017. Chicago, IL. [abstract] J Clin Oncol. 2017 Jun; 35(2017).
Maiese EM, Le Moine JG, Ainsworth C, Ahdesmaki O, Hawe E. Comparative efficacy of multiple myeloma therapies for treatment of first relapse: a systematic literature review and network meta-analysis. Poster presented at the 2017 ASCO Annual Meeting; June 5, 2017. Chicago, IL. [abstract] J Clin Oncol. 2017 Jun; 35(2017).
Li X, McGuinness JE, Vanegas A, Colbeth H, Vargas J, Sandoval R, Kukafka R, Crew KD. Identifying women at high-risk for breast cancer using data from the electronic health record compared with self-report. J Clin Oncol. 2017 May 30;35(15_Suppl):e13044. doi: 10.1200/JCO.2017.35.15_suppl.e13044
Telfort J, Trivedi MS, Yi HS, Colbeth H, Vanegas A, Vargas J, Sandoval R, Wood J, Dimond J, Finkelstein J, Kukafka R, Crew KD. Implementing decision support for breast cancer chemoprevention in primary care. J Clin Oncol. 2017 May;35(15 Suppl):e13038. doi: 10.1200/JCO.2017.35.15_suppl.e13038
McGuinness JE, Trivedi MS, Vanegas A, Colbeth H, Sandoval R, Kukafka R, Crew KD. Decision support for family history intake to determine eligibility for BRCA testing among multiethnic women. J Clin Oncol. 2017 May;35(15_Suppl):1586. doi: 10.1200/JCO.2017.35.15_suppl.1586
Kaye JA, Saltus CW, Calingaert B, Harris DH, Hunter S, Zong J, Brobert GP, Soriano-Gabarro M, Andrews EB. Incidence of Second Primary Malignancies (SPM) in men with Castration-Resistant Prostate Cancer (CRPC) in SEER-Medicare database. J Clin Oncol. 2017 May;2017(35):e13080.